Acta Med. 2004, 47: 129-131

https://doi.org/10.14712/18059694.2018.78

Pyrimidine 5’Nucleotidase I and II Activities in Acute Leukaemias

Haci Kemal Erdemlia, Bahattin Adama, Nüket Bavbekb

aFatih University, Faculty of Medicine, Department of Biochemistry and Clinical Biochemistry, Ankara, Turkey
bFatih University, Faculty of Medicine, Department of Internal Medicine, Ankara, Turkey

Received July 1, 2003
Accepted January 1, 2004

References

1. Agostinho AB, Rosi F, Carlucci F et al. Ecto-5’-nucleotidase activity in lymphocytes from healthy and leukemia patients. Adv Exp Med Biol 1994; 370:227–30. <https://doi.org/10.1007/978-1-4615-2584-4_48>
2. Amici A, Emanuelli M, Raffaelli N, Ruggieri S, Magni G. One-Minute High- Performance Liquid Chromatography Assay for 5’-nucleotidase using a 20–mm reverse-phase column. Anal Biochem 1994; 216:1–5. <https://doi.org/10.1006/abio.1994.1022>
3. Boyum A. Separation of leukocytes from blood and bone marrow. Scand J Cilin Invest 1968; 21:77.
4. Camici M, Tozzi MG, Allegrini S et al. Purine salvage activities in normal and neoplastic human tissues. Cancer Biochem Biophys 1990; 11:201–9.
5. Drexler HG, Gaedicke G, Minowada J. Biochemical enzyme analysis in acute leukaemia. J Clin Pathol 1985; 38:117–27. <https://doi.org/10.1136/jcp.38.2.117> <PubMed>
6. Hopkinson DA, Swallow DM, Marinaki A, Harley EH. Pyrimidine 5’-nucleotidase activity in normal and deficient human lymphoblastoid cells. J Inherit Metab Dis 1990; 13:701–6. <https://doi.org/10.1007/BF01799571>
7. Itoh R, Yamada K. Determination of cytoplasmic 5’-nucleotidase which preferentially hydrolyses 6–hydroxypurine nucleotides in pig, rat and human tissues by immunotitration. Int J Biochem 1991; 23:461–5. <https://doi.org/10.1016/0020-711X(91)90179-Q>
8. Pieters R, Huismans DR, Loonen AH et al. Relation of 5’ nucleotidase and phosphatase activities with immunophenotype, drug resistance and clinical prognosis in childhood leukemia. Leuk Res 1992; 15:873–80. <https://doi.org/10.1016/0145-2126(92)90033-4>
9. Reaman GH, Blatt J, Poplack DG. Lymphoblast purine pathway enzymes in B-cell acute lymphoblastic leukemia. Blood 1981; 58:330–2.
10. Rosi F, Agostinho AB, Tabucchi A. Endo-5’-nucleotidase activity in lzmphocytes from healthy subjects and leukemia patients. Adv Exp Med Biol 1994; 370:231–5. <https://doi.org/10.1007/978-1-4615-2584-4_49>
11. Rosi F, Tabucchi A, Carlucci F et al. 5’-nucleotidase activity in lzmphocytes from patients affected by B-cell chronic lymphocytic leukemia. Clin Biochem 1998; 31:269–72. <https://doi.org/10.1016/S0009-9120(98)00017-4>
12. Sun AS, Renaud M. Enhancement of 5’-nucleotidase activity of human leukemic cells after fractionation: implications for cancer and aging. Mutat Res 1989; 219:295–302. <https://doi.org/10.1016/0921-8734(89)90031-3>
13. Turriani M, Pesi R, Nardone A et al. Cytosolic 5’-nucleotidase/nucleoside phosphotransferase: a nucleoside analog activating enzyme. J Biochem Toxicol 1994; 9:51–7. <https://doi.org/10.1002/jbt.2570090108>
14. Vives Corrons JL, Pujdes MA, Sierra J, Ribera JM. Characteristics of red cell pyruvate kinase and pyrimidine 5’ nucleotidase abnormalities in acute and chronic lymphoid diseases with leukaemic expression. Br J Haematol 1987; 66:173–7.
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive